DaVita HealthCare Partners Company Profile (NYSE:DVA)

About DaVita HealthCare Partners (NYSE:DVA)

DaVita HealthCare Partners logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services - NEC
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:DVA
  • CUSIP: 23918K10
  • Web: www.davita.com
  • Market Cap: $12.92534 billion
  • Outstanding Shares: 194,600,000
Average Prices:
  • 50 Day Moving Avg: $64.83
  • 200 Day Moving Avg: $66.03
  • 52 Week Range: $54.50 - $78.40
  • Trailing P/E Ratio: 10.80
  • Foreward P/E Ratio: 17.26
  • P/E Growth: 1.61
Sales & Book Value:
  • Annual Revenue: $14.85 billion
  • Price / Sales: 0.86
  • Book Value: $26.41 per share
  • Price / Book: 2.49
  • EBIDTA: $2.46 billion
  • Net Margins: 8.28%
  • Return on Equity: 14.85%
  • Return on Assets: 3.97%
  • Debt-to-Equity Ratio: 1.67%
  • Current Ratio: 1.64%
  • Quick Ratio: 1.57%
  • Average Volume: 1.47 million shs.
  • Beta: 0.89
  • Short Ratio: 2.66
Frequently Asked Questions for DaVita HealthCare Partners (NYSE:DVA)

What is DaVita HealthCare Partners' stock symbol?

DaVita HealthCare Partners trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How were DaVita HealthCare Partners' earnings last quarter?

DaVita HealthCare Partners Inc. (NYSE:DVA) issued its quarterly earnings data on Tuesday, May, 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.82 by $0.02. The business earned $3.70 billion during the quarter, compared to the consensus estimate of $3.69 billion. DaVita HealthCare Partners had a net margin of 8.28% and a return on equity of 14.85%. View DaVita HealthCare Partners' Earnings History.

When will DaVita HealthCare Partners make its next earnings announcement?

DaVita HealthCare Partners is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for DaVita HealthCare Partners.

Where is DaVita HealthCare Partners' stock going? Where will DaVita HealthCare Partners' stock price be in 2017?

10 brokers have issued twelve-month price objectives for DaVita HealthCare Partners' stock. Their forecasts range from $62.00 to $75.00. On average, they expect DaVita HealthCare Partners' share price to reach $68.67 in the next twelve months. View Analyst Ratings for DaVita HealthCare Partners.

Who are some of DaVita HealthCare Partners' key competitors?

Who are DaVita HealthCare Partners' key executives?

DaVita HealthCare Partners' management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer
  • Joel Ackerman, Chief Financial Officer
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care
  • Jeanine M. Jiganti, Chief Compliance Officer
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs
  • Michael D. Staffieri, Chief Operating Officer- Kidney Care
  • Kathleen Alyce Waters, Chief Legal Officer
  • Peter T. Grauer, Lead Director, Independent Director

Who owns DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock is owned by a number of of institutional and retail investors. Top institutional investors include Founders Capital Management LLC (0.05%), Aperio Group LLC (0.04%), Exxonmobil Investment Management Inc. TX (0.02%), Investment House LLC (0.01%), Mn Services Vermogensbeheer B.V. (0.01%) and Deane Retirement Strategies Inc. (0.01%). Company insiders that own DaVita HealthCare Partners stock include Carol Anthony Davidson, Charles Berg, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Kim M Rivera, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for DaVita HealthCare Partners.

Who sold DaVita HealthCare Partners stock? Who is selling DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was sold by a variety of institutional investors in the last quarter, including Investment House LLC, Aperio Group LLC, Exxonmobil Investment Management Inc. TX, Oakbrook Investments LLC, Xact Kapitalforvaltning AB and Smith Shellnut Wilson LLC ADV. Company insiders that have sold DaVita HealthCare Partners stock in the last year include Charles Berg, Javier Rodriguez, Michael David Staffieri and William L Roper. View Insider Buying and Selling for DaVita HealthCare Partners.

Who bought DaVita HealthCare Partners stock? Who is buying DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was acquired by a variety of institutional investors in the last quarter, including Mn Services Vermogensbeheer B.V., Deane Retirement Strategies Inc., Founders Capital Management LLC and Eqis Capital Management Inc.. View Insider Buying and Selling for DaVita HealthCare Partners.

How do I buy DaVita HealthCare Partners stock?

Shares of DaVita HealthCare Partners can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DaVita HealthCare Partners' stock price today?

One share of DaVita HealthCare Partners stock can currently be purchased for approximately $65.76.

MarketBeat Community Rating for DaVita HealthCare Partners (NYSE DVA)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  246 (Vote Underperform)
Total Votes:  489
MarketBeat's community ratings are surveys of what our community members think about DaVita HealthCare Partners and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DaVita HealthCare Partners (NYSE:DVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.10)
Consensus Price Target: $68.67 (4.42% upside)

Analysts' Ratings History for DaVita HealthCare Partners (NYSE:DVA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/26/2017Jefferies Group LLCDowngradeBuy -> Hold$64.89 -> $70.00LowView Rating Details
5/25/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSell$62.00HighView Rating Details
2/17/2017Royal Bank Of CanadaReiterated RatingHold$62.00N/AView Rating Details
12/13/2016Robert W. BairdDowngradeOutperform -> Neutral$68.00 -> $69.00N/AView Rating Details
11/21/2016Bank of America CorporationReiterated RatingHold$68.00N/AView Rating Details
11/1/2016Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
10/13/2016SunTrust Banks, Inc.Set Price TargetHold$66.00N/AView Rating Details
9/20/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$75.00N/AView Rating Details
9/6/2016Citigroup Inc.Initiated CoverageNeutral$71.00N/AView Rating Details
8/9/2016J P Morgan Chase & CoBoost Price TargetNeutral$74.00 -> $75.00N/AView Rating Details
4/6/2016Susquehanna Bancshares IncBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 7/22/2015 forward)


Earnings History for DaVita HealthCare Partners (NYSE:DVA)
Earnings by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Earnings History by Quarter for DaVita HealthCare Partners (NYSE DVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017$0.90N/AView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for DaVita HealthCare Partners (NYSE:DVA)
2017 EPS Consensus Estimate: $3.53
2018 EPS Consensus Estimate: $3.85
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.77$0.84$0.81
Q2 20173$0.90$0.92$0.91
Q3 20173$0.89$0.97$0.93
Q4 20173$0.80$0.92$0.88
Q1 20182$0.87$0.88$0.88
Q2 20182$0.99$1.02$1.01
Q3 20182$1.01$1.02$1.02
Q4 20182$0.89$1.01$0.95
(Data provided by Zacks Investment Research)


Dividend History for DaVita HealthCare Partners (NYSE:DVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for DaVita HealthCare Partners (NYSE:DVA)
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 81.93%
Insider Trades by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Insider Trades by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.74View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.20View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.66View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for DaVita HealthCare Partners (NYSE:DVA)
Latest Headlines for DaVita HealthCare Partners (NYSE:DVA)
americanbankingnews.com logo$3.83 Billion in Sales Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter
www.americanbankingnews.com - July 19 at 12:21 PM
finance.yahoo.com logoDaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : July 18, 2017
finance.yahoo.com - July 18 at 7:37 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (NYSE:DVA) Expected to Post Earnings of $0.90 Per Share
www.americanbankingnews.com - July 17 at 8:12 PM
bizjournals.com logoLongtime physician practice name disappears in Tampa Bay
www.bizjournals.com - July 17 at 6:59 PM
americanbankingnews.com logoReviewing DaVita HealthCare Partners (NYSE:DVA) and Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - July 17 at 12:18 AM
finance.yahoo.com logoDaVita Medical Group Buys Dr. Rahn Shaw Practices in Orlando
finance.yahoo.com - July 14 at 4:04 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - July 11 at 5:34 PM
americanbankingnews.com logoDavita Inc (DVA) Downgraded by BidaskClub
www.americanbankingnews.com - July 8 at 7:46 PM
businesswire.com logoRobbins Arroyo LLP Investigates Whether DaVita Inc. (DVA) Misled Shareholders - Business Wire (press release)
www.businesswire.com - July 8 at 5:39 PM
finance.yahoo.com logoRobbins Arroyo LLP Investigates Whether DaVita Inc. (DVA) Misled Shareholders
finance.yahoo.com - July 8 at 10:20 AM
finance.yahoo.com logoDaVita Inc. Schedules 2nd Quarter 2017 Investor Conference Call
finance.yahoo.com - July 5 at 6:46 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 4 at 1:40 PM
prnewswire.com logoDaVita Medical Group Recognized for Excellence in Coordinated Care - PR Newswire (press release)
www.prnewswire.com - June 29 at 7:35 PM
finance.yahoo.com logoDaVita Medical Group Recognized for Excellence in Coordinated Care
finance.yahoo.com - June 29 at 7:35 PM
americanbankingnews.com logoBrokers Set Expectations for DaVita HealthCare Partners Inc.'s FY2017 Earnings (DVA)
www.americanbankingnews.com - June 28 at 8:02 AM
finance.yahoo.com logoMorning Movers: Arconic Tumbles, DaVita Drops, Coach Rises
finance.yahoo.com - June 26 at 5:44 PM
finance.yahoo.com logoPatient-Steering Allegations Only One Reason DaVita Shares Getting Downgraded
finance.yahoo.com - June 26 at 5:44 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Stock Rating Lowered by Jefferies Group LLC
www.americanbankingnews.com - June 26 at 12:52 PM
feeds.benzinga.com logoInvestigation Relating to 401(k) Plans of DaVita Inc. (NYSE:DVA) Commenced by Stull, Stull & Brody
feeds.benzinga.com - June 23 at 8:59 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Expected to Announce Quarterly Sales of $3.83 Billion
www.americanbankingnews.com - June 23 at 3:18 PM
americanbankingnews.com logoZacks: Brokerages Expect DaVita HealthCare Partners Inc. (DVA) Will Post Earnings of $0.90 Per Share
www.americanbankingnews.com - June 21 at 6:10 PM
finance.yahoo.com logoIs DaVita a Suitable Stock for Value Investors?
finance.yahoo.com - June 20 at 5:32 PM
finance.yahoo.com logoETFs with exposure to DaVita, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 6:44 PM
finance.yahoo.com logoDr. David Mahoney Named Chief Medical Officer of Lifeline Vascular Access
finance.yahoo.com - June 19 at 1:42 PM
finance.yahoo.com logoHealth-Care Investors Are in Denial
finance.yahoo.com - June 16 at 5:38 PM
finance.yahoo.com logoDBJ's best of the week for June 10-16: Inside the Amazon and ViaWest deals, hospital merger talks and more
finance.yahoo.com - June 16 at 5:38 PM
americanbankingnews.com logoDaVita HealthCare Partners Inc. (DVA) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - June 16 at 12:50 PM
finance.yahoo.com logoDaVita Clinical Research Launches Alliance Site Network for Early Stage CKD Trials
finance.yahoo.com - June 15 at 6:51 PM
finance.yahoo.com logoDaVita Celebrates 10 Years of Sustainability
finance.yahoo.com - June 8 at 5:50 PM
finance.yahoo.com logoETFs with exposure to DaVita, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 5:50 PM
finance.yahoo.com logoDaVita Introduces DaVita® Health Solutions
finance.yahoo.com - June 6 at 5:13 PM
finance.yahoo.com logoDaVita, Inc. :DVA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
finance.yahoo.com - June 6 at 5:13 PM
finance.yahoo.com logoRobbins Arroyo LLP: DaVita Inc. (DVA) Misled Shareholders According to a Class Action
finance.yahoo.com - June 6 at 5:13 PM
finance.yahoo.com logoDaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : June 2, 2017
finance.yahoo.com - June 2 at 4:15 PM
finance.yahoo.com logoDBJ's best of the week for May 27-June 2: DaVita CEO's challenges, our money series and more
finance.yahoo.com - June 2 at 4:15 PM
streetinsider.com logoDaVita's (DVA) HealthCare Partners Announce Acquisition of Magan Medical Clinic - StreetInsider.com
www.streetinsider.com - June 2 at 3:33 AM
streetinsider.com logoDaVita's (DVA) HealthCare Partners Announce Acquisition of Magan Medical Clinic
www.streetinsider.com - June 1 at 5:30 PM
finance.yahoo.com logoHealthCare Partners to Acquire Magan Medical Clinic
finance.yahoo.com - June 1 at 5:30 PM
finance.yahoo.com logoDialysis Firms Get Help From Congress in Overturning Charity Ban
finance.yahoo.com - May 31 at 9:49 AM
bizjournals.com logoExclusive: DaVita CEO Kent Thiry, his journey from failure to success and the challenges he faces (Photos)
www.bizjournals.com - May 30 at 11:38 AM
americanbankingnews.com logo Brokerages Anticipate Davita Inc (DVA) Will Announce Quarterly Sales of $3.83 Billion
www.americanbankingnews.com - May 28 at 9:08 AM
americanbankingnews.com logoJefferies Group LLC Analysts Give Davita Inc (DVA) a $70.00 Price Target
www.americanbankingnews.com - May 27 at 8:24 AM
nasdaq.com logoCommit To Purchase DaVita At $57.50, Earn 5.1% Annualized Using Options
www.nasdaq.com - May 26 at 5:25 PM
americanbankingnews.com logoZacks: Analysts Anticipate Davita Inc (DVA) to Announce $0.90 EPS
www.americanbankingnews.com - May 26 at 12:50 PM
finance.yahoo.com logoDaVita Celebrates Military Appreciation Month
finance.yahoo.com - May 26 at 4:45 AM
nasdaq.com logoDaVita (DVA) Shares Cross Above 200 DMA - Nasdaq
www.nasdaq.com - May 25 at 11:44 PM
prnewswire.com logoDaVita adquiere Centrum Dializa II - PR Newswire - PR Newswire (Comunicado de prensa)
www.prnewswire.com - May 25 at 6:43 PM
finance.yahoo.com logoDaVita acquires Polish dialysis company
finance.yahoo.com - May 25 at 6:43 PM
americanbankingnews.com logoDavita Inc (DVA) Given Sell Rating at Goldman Sachs Group Inc
www.americanbankingnews.com - May 25 at 6:11 PM
finance.yahoo.com logoDaVita Kidney Care Welcomes Eric Severson as Chief People Officer
finance.yahoo.com - May 24 at 12:29 PM



DaVita HealthCare Partners (DVA) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff